T1-mapping in the heart: Accuracy and precision

Journal of Cardiovascular Magnetic Resonance

Volumn 16, Issue 1, 2014, Pages

  Kellman, Peter ^a   Hansen, Michael S ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

Accuracy; Cardiovascular magnetic resonance; ECV; MOLLI; Off resonance; Precision; Reproducibility; SASHA; ShMOLLI; T1 map

Indexed keywords

ARTIFACTS; CARDIOMYOPATHIES; CONTRAST MEDIA; FIBROSIS; HEART RATE; HUMANS; MAGNETIC RESONANCE IMAGING; MYOCARDIAL CONTRACTION; MYOCARDIUM; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; VENTRICULAR FUNCTION;

EID: 84891503345     PISSN: 10976647     EISSN: 1532429X     Source Type: Journal    
DOI: 10.1186/1532-429X-16-2     Document Type: Article

References (56)

1. Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement. Moon JC, Messroghli DR, Kellman P, Piechnik SK, Robson MD, Ugander M, Gatehouse PD, Arai AE, Friedrich MG, Neubauer S, Schulz-Menger J, Schelbert EB, J Cardiovasc Magn Reson 2013 15 92 10.1186/1532-429X-15-92 24124732
2. Association between extracellular matrix expansion quantified by cardiovascular magnetic resonance and short-term mortality. Wong TC, Piehler K, Meier CG, Testa SM, Klock AM, Aneizi AA, Shakesprere J, Kellman P, Shroff SG, Schwartzman DS, Mulukutla SR, Simon MA, Schelbert EB, Circulation 2012 126 10 1206 16 10.1161/CIRCULATIONAHA.111.089409 22851543
3. Myocardial extracellular volume fraction quantified by cardiovascular magnetic resonance is increased in diabetes and associated with mortality and incident heart failure admission. Wong TC, Piehler KM, Kang IA, Kadakkal A, Kellman P, Schwartzman DS, Mulukutla SR, Simon MA, Shroff SG, Kuller LH, Schelbert EB, Eur Heart J 2013 doi: 10.1093/eurheartj/eht193
4. Clinical indications for cardiovascular magnetic resonance (CMR): consensus panel report. Pennell DJ, Sechtem UP, Higgins CB, et al. Eur Heart J 2004 25 1940 65 10.1016/j.ehj.2004.06.040 15522474 (Pubitemid 39452612)
5. Myocardial late enhancement in contrast-enhanced cardiac MRI: distinction between infarction scar and non-infarction-related disease. Hunold P, Schlosser T, Vogt FM, et al. Am J Roentgenol 2005 184 5 1420 6 10.2214/ajr.184.5.01841420 (Pubitemid 43821809)
6. Novel imaging techniques for diffuse myocardial fibrosis. Sado DM, Flett AS, Moon JC, Future Cardiol 2011 7 5 643 50 10.2217/fca.11.45 21929344
7. Assessment of myocardial fibrosis with cardiovascular magnetic resonance. Mewton N, Liu CY, Croisille P, Bluemke D, Lima JA, J Am Coll Cardiol 2011 57 8 891 903 10.1016/j.jacc.2010.11.013 21329834
8. T1 mapping of the gadolinium- enhanced myocardium: adjustment for factors affecting interpatient comparison. Gai N, Turkbey EB, Nazarian S, et al. Magn Reson Med 2011 65 5 1407 15 10.1002/mrm.22716 21500267
9. Myocardial T1 and extracellular volume fraction mapping at 3 tesla. Lee JJ, Liu S, Nacif MS, Ugander M, Kawel N, Sibley CT, Kellman P, Arai A, Bluemke DA, J Cardiovasc Magn Reson 2011 13 1 75 10.1186/1532-429X-13-75 22123333
10. Measurement of the distribution volume of gadopentetate dimeglumine at echo-planar mr imaging to quantify myocardial infarction: comparison with 99mtc-dtpa autoradiography in rats. Arheden H, Saeed M, Higgins CB, et al. Radiology 1999 211 698 708 10.1148/radiology.211.3.r99jn41698 10352594 (Pubitemid 29249466)
11. Cardiac magnetic resonance imaging of myocardial contrast uptake and blood flow in patients affected with idiopathic or familial dilated cardiomyopathy. Jerosch-Herold M, Sheridan DC, Kushner JD, et al. Am J Physiol Heart Circ Physiol 2008 295 1234 42 10.1152/ajpheart.00429.2008 18660445
12. Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans. Flett AS, Hayward MP, Ashworth MT, et al. Circulation 2010 122 2 138 44 10.1161/CIRCULATIONAHA.109.930636 20585010
13. Gadolinium-enhanced magnetic resonance imaging for detection and quantification of fibrosis in human myocardium in vitro. Kehr E, Sono M, Chugh S, Jerosch-Herold M, Int J Cardiovasc Imaging 2008 24 61 8 17429755 (Pubitemid 350263105)
14. Quantification of diffuse myocardial fibrosis and its association with myocardial dysfunction in congenital heart disease. Broberg CS, Chugh S, Conklin C, Sahn DJ, Jerosch-Herold M, Circ Cardiovasc Imaging 2010 3 727 34 10.1161/CIRCIMAGING.108.842096 20855860
15. Myocardial extracellular volume fraction measurement by gadolinium cardiovascular magnetic resonance in humans: slow infusion versus bolus. Schelbert E, Testa SM, Meier CG, et al. J Cardiovasc Magn Reson 2011 13 16 10.1186/1532-429X-13-16 21375743
16. Extracellular volume imaging by MRI provides insight into overt and subclinical myocardial pathology. Ugander M, Oki AJ, Hsu L-Y, et al. Eur Heart J 2012 33 10 1268 78 10.1093/eurheartj/ehr481 22279111
17. Extracellular volume fraction mapping in the myocardium, part 2: initial clinical experience. Kellman P, Wilson JR, Xue H, Bandettini WP, Shanbhag SM, Druey KM, Ugander M, Arai AE, J Cardiovasc Magn Reson 2012 14 64 10.1186/1532-429X-14-64 22967246
18. Native T1 mapping in differentiation of normal myocardium from diffuse disease in hypertrophic and dilated cardiomyopathy. Puntmann VO, Voigt T, Chen Z, Mayr M, Karim R, Rhode K, Pastor A, Carr-White G, Razavi R, Schaeffter T, Nagel E, JACC Cardiovasc Imaging 2013 6 475 84 10.1016/j.jcmg.2012.08.019 23498674
19. T1 mapping in patients with acute myocardial infarction. Messroghli DR, Niendorf T, Schulz-Menger J, Dietz R, Friedrich MG, J Cardiovasc Magn Reson 2003 5 353 9 10.1081/JCMR-120019418 12765114 (Pubitemid 36569954)
20. Myocardial T1 mapping: application to patients with acute and chronic myocardial infarction. Messroghli DR, Walters K, Plein S, Sparrow P, Friedrich MG, Ridgway JP, Sivananthan MU, Magn Reson Med 2007 58 34 40 10.1002/mrm.21272 17659622 (Pubitemid 47229915)
21. Myocardial edema as detected by pre-contrast T1 and T2 MRI delineates area at risk associated with acute myocardial infarction. Ugander M, Bagi PS, Oki AJ, et al. JACC Cardiovasc Imaging 2012 5 6 596 603 10.1016/j.jcmg.2012.01. 016 22698528
22. Non-contrast T1-mapping detects acute myocardial edema with high diagnostic accuracy: a comparison to T2-weighted cardiovascular magnetic resonance. Ferreira VM, Piechnik SK, Dall'Armellina E, Karamitsos TD, Francis JM, Choudhury RP, Friedrich MG, Robson MD, Neubauer S, J Cardiovasc Magn Reson 2012 14 42 10.1186/1532-429X-14-42 22720998
23. Cardiovascular magnetic resonance by non contrast T1-mapping allows assessment of severity of injury in acute myocardial infarction. Dall'Armellina E, Piechnik SK, Ferreira VM, Si QL, Robson MD, Francis JM, Cuculi F, Kharbanda RK, Banning AP, Choudhury RP, Karamitsos TD, Neubauer S, J Cardiovasc Magn Reson 2012 14 15 10.1186/1532-429X-14-15 22309452
24. T1 mapping for the diagnosis of acute myocarditis using CMR: comparison to T2-weighted and late gadolinium enhanced imaging. Ferreira VM, Piechnik SK, Dall'armellina E, Karamitsos TD, Francis JM, Ntusi N, Holloway C, Choudhury RP, Kardos A, Robson MD, Friedrich MG, Neubauer S, JACC Cardiovasc Imaging 2013 doi:10.1016/j.jcmg.2013.03.008 [Epub ahead of print]
25. Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis. Karamitsos TD, Piechnik SK, Banypersad SM, Fontana M, Ntusi NB, Ferreira VM, Whelan CJ, Myerson SG, Robson MD, Hawkins PN, Neubauer S, Moon JC, JACC Cardiovasc Imaging 2013 6 488 97 10.1016/j.jcmg.2012.11.013 23498672
26. Native myocardial T1 mapping by cardiovascular magnetic resonance imaging in subclinical cardiomyopathy in patients with systemic lupus erythematosus. Puntmann VO, D'Cruz D, Smith Z, Pastor A, Choong P, Voigt T, Carr-White G, Sangle S, Schaeffter T, Nagel E, Circ Cardiovasc Imaging 2013 6 295 301 10.1161/CIRCIMAGING.112.000151 23403334
27. The identification and assessment of Anderson Fabry disease by cardiovascular magnetic resonance non-contrast myocardial T1 mapping. Sado DM, White SK, Piechnik SK, Banypersad SM, Treibel T, Captur G, Fontana M, Maestrini V, Flett AS, Robson MD, Lachmann RH, Murphy E, Mehta A, Hughes D, Neubauer S, Elliott PM, Moon JC, Circ Cardiovasc Imaging 2013 6 392 8 23564562
28. Assessment of intramyocardial hemorrhage by T1-weighted cardiovascular magnetic resonance in reperfused acute myocardial infarction. Pedersen SF, Thrysoe SA, Robich MP, Paaske WP, Ringgaard S, Botker HE, Hansen ES, Kim WY, J Cardiovasc Magn Reson 2012 14 59 10.1186/1532-429X-14-59 22935462
29. In vivo comparison of myocardial T1 with T2 and T2* in thalassaemia major. Feng Y, He T, Carpenter J-P, Jabbour A, Alam MH, Gatehouse PD, Greiser A, Messroghli D, Firmin DN, Pennell DJ, J Magn Reson Imaging 2013 38 588 93 10.1002/jmri.24010 23371802
30. Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping. Iles L, Pfluger H, Phrommintikul A, Cherayath J, Aksit P, Gupta SN, Kaye DM, Taylor AJ, J Am Coll Cardiol 2008 52 1574 80 10.1016/j.jacc.2008.06.049 19007595
31. Cardiac imaging abbreviations: gadopentetate dimeglumine partition coefficient in human myocardium in vivo: normal distribution and elevation in acute and chronic infarction. Flacke SJ, Fischer SE, Lorenz CH, Radiology 2001 218 703 710 10.1148/radiology.218.3.r01fe18703 11230643 (Pubitemid 32172551)
32. Modified Look-Locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart. Messroghli DR, Radjenovic A, Kozerke S, Higgins DM, Sivananthan MU, Ridgway JP, Magn Reson Med 2004 52 141 6 10.1002/mrm.20110 15236377 (Pubitemid 39295266)
33. Shortened Modified Look-Locker Inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3 T within a 9 heartbeat breathhold. Piechnik SK, Ferreira VM, Dall'Armellina E, Cochlin LE, Greiser A, Neubauer S, Robson MD, J Cardiovasc Magn Reson 2010 12 69 10.1186/1532-429X-12-69 21092095
34. Extracellular volume fraction mapping in the myocardium, part 1: evaluation of an automated method. Kellman P, Wilson JR, Xue H, Ugander M, Arai AE, J Cardiovasc Magn Reson 2012 14 63 10.1186/1532-429X-14-63 22963517
35. Motion correction for myocardial T1 mapping using image registration with synthetic image estimation. Xue H, Shah S, Greiser A, et al. Magn Reson Med 2012 67 6 1644 55 10.1002/mrm.23153 22135227
36. Phase-sensitive inversion recovery for myocardial T(1) mapping with motion correction and parametric fitting. Xue H, Greiser A, Zuehlsdorff S, Jolly MP, Guehring J, Arai AE, Kellman P, Magn Reson Med 2013 69 5 1408 20 10.1002/mrm.24385 22736380
37. Optimization and validation of a fully-integrated pulse sequence for modified look- locker inversion-recovery (MOLLI) T1mapping of the heart. Messroghli DR, Greiser A, Frohlich M, Dietz R, Schulz-Menger J, J Magn Reson Imaging 2007 26 1081 6 10.1002/jmri.21119 17896383 (Pubitemid 47548170)
38. Modified Look-Locker T(1) evaluation using Bloch simulations: human and phantom validation. Gai ND, Stehning C, Nacif M, Bluemke D, Magn Reson Med 2013 69 2 329 336 10.1002/mrm.24251 22457268
39. Comparison of methods for determining the partition coefficient of gadolinium in the myocardium using T(1) mapping. Salerno M, Janardhanan R, Jiji RS, Brooks J, Adenaw N, Mehta B, Yang Y, Antkowiak P, Kramer CM, Epstein FH, J Magn Reson Imaging 2013 38 1 217 224 10.1002/jmri.23875 23197434
40. Adiabatic inversion pulses for myocardial T1-mapping. Kellman P, Herzka DA, Hansen MS, Magn Res Med 2013 doi:10.1002/mrm.24793. [Epub ahead of print]
41. T1 and extracellular volume mapping in the heart: estimation of error maps and the influence of noise on precision. Kellman P, Arai AE, Xue H, J Cardiovasc Magn Reson 2013 15 56 10.1186/1532-429X-15-56 23800276
42. Influence of Off-resonance in myocardial T1-mapping using SSFP based MOLLI method. Kellman P, Herzka DA, Arai AE, Hansen MS, J Cardiovasc Magn Reson 2013 15 63 10.1186/1532-429X-15-63 23875774
43. T1 measurement using a short acquisition period for quantitative cardiac applications. Higgins DM, Ridgway JP, Radjenovic A, Sivananthan UM, Smith MA, Med Phys 2005 32 1738 10.1118/1.1921668 16013731 (Pubitemid 40883095)
44. Saturation recovery single-shot acquisition (SASHA) for myocardial T1 mapping. Chow K, Flewitt JA, Green JD, Pagano JJ, Friedrich MG, Thompson RB, Magn Reson Med 2013 doi: 10.1002/mrm.24878. [Epub ahead of print]
45. Combined saturation/inversion recovery sequences for improved evaluation of scar and diffuse fibrosis in patients with arrhythmia or heart rate variability. Weingärtner S, Akçakaya M, Basha T, Kissinger KV, Goddu B, Berg S, Manning WJ, Nezafat R, Magn Reson Med 2013 doi: 10.1002/mrm.24761. [Epub ahead of print]
46. Quantification of Tl Values by SNAPSHOT-FLASH NMR Imaging. Deichmann R, Haase A, J Magn Reson 1992 612 608 12
47. Inversion recovery TrueFISP: quantification of T(1), T(2), and spin density. Schmitt P, Griswold MA, Jakob PM, Kotas M, Gulani V, Flentje M, Haase A, Magn Reson Med 2004 51 661 667 10.1002/mrm.20058 15065237 (Pubitemid 38420441)
48. Flexible cardiac T1 mapping using a modified Look-Locker acquisition with saturation recovery. Song T, Stainsby JA, Ho VB, Hood MN, Slavin GS, Magn Reson Med 2012 67 622 627 10.1002/mrm.24137 22344580
49. Design and use of tailored hard-pulse trains for uniformed saturation of myocardium at 3 Tesla. Sung K, Nayak KS, Magn Reson Med 2008 60 997 1002 10.1002/mrm.21765 18816833
50. Normal variation of magnetic resonance T1 relaxation times in the human population at 1.5 T using ShMOLLI. Piechnik SK, Ferreira VM, Lewandowski AJ, Ntusi NAB, Banerjee R, Holloway C, Hofman MBM, Sado DM, Maestrini V, White SK, Lazdam M, Karamitsos T, Moon JC, Neubauer S, Leeson P, Robson MD, J Cardiovasc Magn Reson 2013 15 13 10.1186/1532-429X-15-13 23331520
51. T1 measurements in the human myocardium: the effects of magnetization transfer on the SASHA and MOLLI sequences. Robson MD, Piechnik SK, Tunnicliffe EM, Neubauer S, Magn Reson Med 2013 670 664 70
52. Magnetization transfer on in vitro circulating blood: implications for time-of-flight angiography. Dousset V, Degreze P, Mieze S, Sessay M, Basse-Cathalinat B, Caille J-M, JMRI 1995 5 786 8 10.1002/jmri.1880050630 8748505
53. Magnetization transfer effects on the efficiency of flow-driven adiabatic fast passage inversion of arterial blood. Hernandez-Garcia L, Lewis DP, Moffat B, Branch CA, NMR Biomed 2007 20 733 42 10.1002/nbm.1137 17304639 (Pubitemid 350285270)
54. Magnetization transfer time-of-flight magnetic resonance angiography. Pike GB, Hu BS, Glover GH, Enzmann DR, Magn Reson Med 1992 25 372 9 10.1002/mrm.1910250217 1614322
55. Comprehensive validation of cardiovascular magnetic resonance techniques for the assessment of myocardial extracellular volume. Miller CA, Naish JH, Bishop P, Coutts G, Clark D, Zhao S, Ray SG, Yonan N, Williams SG, Flett AS, Moon JC, Greiser A, Parker GJM, Schmitt M, Circ Cardiovasc Imaging 2013 6 373 83 23553570
56. T1 mapping of the myocardium: intra-individual assessment of post-contrast T1 time evolution and extracellular volume fraction at 3T for Gd-DTPA and Gd-BOPTA. Kawel N, Nacif M, Zavodni A, Jones J, Liu S, Sibley CT, Bluemke DA, J Cardiovasc Magn Reson 2012 14 26 10.1186/1532-429X-14-26 22540153